Provides gene editing technologies, engineered cell lines, and research reagents used by pharmaceutical and biotechnology companies in drug discovery and genomic research. Its platforms have been widely used for CRISPR-based gene editing, functional genomics, and biomarker development. Investors hav...
No congressional trades have been disclosed for Horizon Discovery Ordinary (HZD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.